δ-Opioid Receptor Activation Modified MicroRNA Expression in the Rat Kidney under Prolonged Hypoxia

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  He, Xiaozhou ^a   Yang, Yilin ^a   Zhi, Feng ^a   Moore, Meredith L ^b   Kang, Xuezhi ^c   Chao, Dongman ^b,d   Wang, Rong ^a   Balboni, Gianfranco ^e   Salvadori, Severo ^f   Kim, Dong H ^b   Xia, Ying ^b,d  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Shanghai Research Center for Acupuncture and Meridians   (China)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; MICRORNA; MICRORNA 101B; MICRORNA 186; MICRORNA 187; MICRORNA 20B 3P; MICRORNA 20B 5P; MICRORNA 21; MICRORNA 212; MICRORNA 25; MICRORNA 291A 5P; MICRORNA 292 5P; MICRORNA 298; MICRORNA 29A; MICRORNA 29B; MICRORNA 324 3P; MICRORNA 347; MICRORNA 351; MICRORNA 363; MICRORNA 365; MICRORNA 370; MICRORNA 431; MICRORNA 466B; MICRORNA 487B; MICRORNA 511; MICRORNA 615 5P; MICRORNA 743A; MICRORNA LET 7D; MICRORNA LET 7F; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE REGULATORY NETWORK; HYPOXIA; KIDNEY ISCHEMIA; KIDNEY MASS; LONG TERM EXPOSURE; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WEIGHT CHANGE;

ANIMALS; ANOXIA; BODY WEIGHT; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY; MALE; MICRORNAS; ORGAN SIZE; RATS; RECEPTORS, OPIOID, DELTA;

RATTUS;

EID: 84876186131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061080     Document Type: Article

References (52)

1. Nangaku M, Eckardt KU, (2007) Hypoxia and the HIF system in kidney disease. J Mol Med 85: 1325-1330.
2. Heyman SN, Khamaisi M, Rosen S, Rosenberger C, (2008) Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease. Am J Nephrol 28: 998-1006.
3. Martínez-Ballarín E, Pié J, Martínez-Berganza A, (1986) Effects of chronic hypoxia on kidney function. Rev Esp Fisiol 42: 319-322.
4. White NMA, Yousef GM, (2010) MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. BMC Med 8: 65.
5. Liang M, Liu Y, Mladinov D, Cowley AW, Trivedi H Jr, et al. (2009) MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol 297: F553-F558.
6. Ma MC, Qian H, Ghassemi F, Zhao P, Xia Y, (2005) Oxygen sensitive delta-opioid receptor-regulated survival and death signals: Novel insights into neuronal preconditioning and protection. J Biol Chem 280: 16208-16218.
7. Zhang J, Qian H, Zhao P, Hong SS, Xia Y, (2006) Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-Opioid Receptor. Stroke 37: 1094-1099.
8. Feng Y, He X, Yang Y, Chen J, Yin K, et al. (2011) Effect of delta-opioid receptor over-expression on cortical expression of GABAA receptor a1-subunit in hypoxia, Chin J Physiol. 54: 118-123.
9. Zhang JH, Haddad GG, Xia Y, (2000) δ-, but not μ- and κ-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res 885: 143-153.
10. Kang X, Chao D, Gu Q, Ding G, Wang Y, et al. (2009) Delta-opioid receptor activation decreases anoxic Na+ influx and K+ leakage via sodium channel regulation. Cell Mol Life Sci 66: 3505-3516.
11. Yang Y, Xia X, Zhang Y, Wang Q, Li L, et al. (2009) Delta-opioid receptor activation attenuates oxidative injury in the ischemic rat brain. BMC Biol 7: 55.
12. Chao D, Donnelly DF, Feng Y, Bazzy-Asaad A, Xia Y, (2007) Cortical delta-opioid receptors potentiate K+ homeostasis during anoxia and oxygen-glucose deprivation. J Cereb Blood Flow Metab 27: 356-368.
13. Chao D, Bazzy-Asaad A, Gianfranco B, Xia Y, (2007) Delta-, but not μ-, opioid receptor stabilizes K+ homeostasis by reducing Ca2+ influx in the cortex during acute hypoxia. J Cell Physiol 212: 60-67.
14. Chao D, Bazzy-Asaad A, Balboni G, Salvadori S, Xia Y, (2008) Activation of DOR attenuates anoxic K+ derangement via inhibition of Na+ entry in mouse cortex. Cereb Cortex 18: 2217-2227.
15. Chao D, Balboni G, Lazarus LH, Salvadori S, Xia Y, (2009) Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cell Mol Life Sci 66: 1105-1115.
16. Chao D, Xia Y, (2010) Ionic storm in hypoxic/ischemic stress: Can opioid receptors subside it? Prog Neurobiol 90: 439-470.
17. Chao D, He X, Yang Y, Bazzy-Asaad A, Lazarus LH, et al. (2012) DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex. Exp Neurol 236: 228-239.
18. Patel HH, Head BP, Petersen HN, Niesman IR, Huang D, et al. (2006) Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. Am J Physiol Heart Circ Physiol 291: H344-H350.
19. Borlongan CV, Wang Y, Su TP, (2004) Delta opioid peptide (D-Ala 2, D-Leu 5) enkephalin: linking hibernation and neuroprotection. Front Biosci 9: 3392-3398.
20. Wu Q, Hwang CK, Zheng H, Wagley Y, Lin HY, et al. (2013) MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment. FASEB J 27: 522-535.
21. He Y, Yang C, Kirkmire CM, Wang ZJ, (2010) Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J Neurosci 30: 10251-10258.
22. Zheng H, Chu J, Zeng Y, Loh HH, Law PY, (2010) Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem 285: 21994-22002.
23. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, et al. (2010) miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224: 242-249.
24. Lei Z, Li B, Yang Z, Fang H, Zhang GM, et al. (2009) Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4: e7629.
25. Gonsalves CS, Kalra VK, (2010) Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p. J Immunol 184: 3878-3888.
26. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, et al. (2011) Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis 17: 221-231.
27. Polytarchou C, Iliopoulos D, Hatziapostolou M, Kottakis F, Maroulakou I, et al. (2011) Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation. Cancer Res 71: 4720-4731.
28. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, et al. (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845.
29. Luna C, Li G, Qiu J, Epstein DL, Gonzalez P, (2009) Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress. Mol Vis 15: 2488-2497.
30. Hulsmans M, De Keyzer D, Holvoet P, (2011) MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 25: 2515-2527.
31. Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M, (2012) The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 44: 237-244.
32. Cui Y, Su W-Y, Xing J, Wang Y-C, Wang P, et al. (2011) MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 6: e25872.
33. Ye Y, Perez-Polo JR, Qian J, Birnbaum Y, (2011) The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics 43: 534-542.
34. Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, et al. (2008) Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 32: 355-364.
35. Hempel C, Combes V, Hunt NH, Kurtzhals JA, Grau GE, (2011) CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am J Pathol 179: 1939-1950.
36. Kato S, Aoyama M, Kakita H, Hida H, Kato I, et al. (2011) Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J Neurosci Res 89: 1566-1574.
37. Li J, Lu Y, Zhang J, Kang H, Qin Z, et al. (2010) PI4KIIalpha is a novel regulator of tumor growth by its action on angiogenesis and HIF-1alpha regulation. Oncogene 29: 2550-2559.
38. Saito A, Miyauchi N, Hashimoto T, Karasawa T, Han GD, et al. (2011) Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys. Am J Physiol Regul Integr Comp Physiol 300: R340-R348.
39. Saito A, Miyauchi N, Hashimoto T, Karasawa T, Han GD, et al. (2011) Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys. Am J Physiol Regul Integr Comp Physiol 300: R340-R348.
40. Bondeva T, Ruster C, Franke S, Hammerschmid E, Klagsbrun M, et al. (2009) Advanced glycation end-products suppress neuropilin-1 expression in podocytes. Kidney Int 75: 605-616.
41. Xia Y, Eisenman D, Haddad GG, (1993) Sulfonylurea receptor expression in rat brain: effect of chronic hypoxia during development. Pediatric Res 34: 634-641.
42. Xia Y, Warshaw JB, Haddad GG, (1995) Chronic hypoxia causes opposite effects on glucose transporter 1 mRNA in mature versus immature rat brain. Brain Res 675: 224-230.
43. Xia Y, Warshaw JB, Haddad GG, (1997) Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult rats Am J Physiol. 273: R1734-R1741.
44. Bodnar RJ, (1998) Recent advances in the understanding of the effects of opioid agents on feeding and appetite. Expert Opin Investig Drugs 7: 485-497.
45. Israel Y, Kandov Y, Khaimova E, Kest A, Lewis SR, et al. (2005) NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. Peptides 26: 1167-1175.
46. Xia Y, Haddad GG, (1994) Effect of prolonged O2 deprivation on Na+ channels: differential regulation in adult versus fetal rat brain. Neuroscience 94: 1231-1243.
47. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, et al. (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101: 9740-9744.
48. Thomson JM, Parker J, Perou CM, Hammond SM, (2004) A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53.
49. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
50. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
51. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
52. Tang F, Hajkova P, Barton SC, Lao K, Surani MA, (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34: e9.